eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | polycystic ovary syndrome |
| Comorbidity | C0020514|hyperprolactinemia |
| Sentences | 3 |
| PubMedID- 25999998 | Conclusion: the results showed that cabergoline can be used as a safe administration in pcos patients with hyperprolactinemia to improve the menstrual cycles. |
| PubMedID- 26007259 | The distribution was pcos with hyperprolactinemia 18.6%, pcos with hypothyroidism 11.4%, pcos with metabolic syndrome 15.3%, pcos with hyperprolactinemia with ms 8.6%, pcos with hypothyrodism with ms 5.6%, pcos with hypothyrodism with hyperprolactinemia 4.3% and rest 4.3% had all the 4 in combination. |
| PubMedID- 21388855 | Therefore, hyperprolactinemia in women with pcos must lead to etiological investigations, including eliminating macroprolactinemia (excess of "big prolactin" and/or "big-big prolactin"). |
Page: 1